123 related articles for article (PubMed ID: 33872794)
1. PET/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosis.
Husmann L; Muehlematter UJ; Grimm F; Ledergerber B; Messerli M; Kudura K; Gruenig H; Muellhaupt B; Hasse B; Huellner MW
Parasitol Int; 2021 Aug; 83():102356. PubMed ID: 33872794
[TBL] [Abstract][Full Text] [Related]
2. Prediction of benzimidazole therapy duration with PET/CT in inoperable patients with alveolar echinococcosis.
Husmann L; Gruenig H; Reiner CS; Deibel A; Ledergerber B; Liberini V; Skawran S; Muehlematter UJ; Messerli M; Hasse B; Muellhaupt B; Huellner MW
Sci Rep; 2022 Jul; 12(1):11392. PubMed ID: 35794149
[TBL] [Abstract][Full Text] [Related]
3. Follow-up PET/CT of alveolar echinococcosis: Comparison of metabolic activity and immunodiagnostic testing.
Husmann L; Deibel A; Skawran S; Ledergerber B; Muehlematter UJ; Hasse B; Huellner MW; Reiner CS; Muellhaupt B
PLoS One; 2022; 17(6):e0270695. PubMed ID: 35767557
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-Weighted MRI for the Initial Viability Evaluation of Parasites in Hepatic Alveolar Echinococcosis: Comparison with Positron Emission Tomography.
Zheng J; Wang J; Zhao J; Meng X
Korean J Radiol; 2018; 19(1):40-46. PubMed ID: 29353998
[TBL] [Abstract][Full Text] [Related]
6. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy.
Stumpe KD; Renner-Schneiter EC; Kuenzle AK; Grimm F; Kadry Z; Clavien PA; Deplazes P; von Schulthess GK; Muellhaupt B; Ammann RW; Renner EL
Infection; 2007 Feb; 35(1):11-8. PubMed ID: 17297583
[TBL] [Abstract][Full Text] [Related]
7. Biological characteristics of 18F-FDG PET/CT imaging of cerebral alveolar echinococcosis.
Yibulayin A; Li XH; Qin YD; Jia XY; Zhang QZ; Li YB
Medicine (Baltimore); 2018 Sep; 97(39):e11801. PubMed ID: 30278480
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/MRI imaging for the management of alveolar echinococcosis: initial clinical experience at a reference centre in Austria.
Lötsch F; Waneck F; Groger M; Auer H; Kaczirek K; Rausch I; Wadsak W; Hacker M; Lagler H; Ramharter M; Karanikas G
Trop Med Int Health; 2019 Jun; 24(6):663-670. PubMed ID: 30851233
[TBL] [Abstract][Full Text] [Related]
10. Outcome after Discontinuing Long-Term Benzimidazole Treatment in 11 Patients with Non-resectable Alveolar Echinococcosis with Negative FDG-PET/CT and Anti-EmII/3-10 Serology.
Ammann RW; Stumpe KD; Grimm F; Deplazes P; Huber S; Bertogg K; Fischer DR; Müllhaupt B
PLoS Negl Trop Dis; 2015; 9(9):e0003964. PubMed ID: 26389799
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the clinical value of
Qin Y; Li X; Zhang Q; Xie B; Ji X; Li Y; Yiblayan A; Wen H
Exp Ther Med; 2016 Jan; 11(1):43-48. PubMed ID: 26889215
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a structured treatment discontinuation in patients with inoperable alveolar echinococcosis on long-term benzimidazole therapy: A retrospective cohort study.
Deibel A; Stocker D; Meyer Zu Schwabedissen C; Husmann L; Kronenberg PA; Grimm F; Deplazes P; Reiner CS; Müllhaupt B
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010146. PubMed ID: 35089933
[TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT used in identifying adult-onset Still's disease in connective tissue diseases.
Zhou X; Li Y; Wang Q
Clin Rheumatol; 2020 Sep; 39(9):2735-2742. PubMed ID: 32180040
[TBL] [Abstract][Full Text] [Related]
14. Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified 18F-FDG-PET-CT.
Kaltenbach TE; Graeter T; Mason RA; Kratzer W; Oeztuerk S; Haenle MM; Gruener B; Gottstein M
Nuklearmedizin; 2015; 54(1):43-9. PubMed ID: 25423884
[TBL] [Abstract][Full Text] [Related]
15. Comparison of [
Li J; Dong J; Yang L; Li X; Song T
Ultrasound Med Biol; 2018 Nov; 44(11):2199-2208. PubMed ID: 30077410
[TBL] [Abstract][Full Text] [Related]
16. Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
Alongi P; Caobelli F; Gentile R; Stefano A; Russo G; Albano D; Baldari S; Gilardi MC; Midiri M
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):224-233. PubMed ID: 27565154
[TBL] [Abstract][Full Text] [Related]
17. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography.
Ehrhardt AR; Reuter S; Buck AK; Haenle MM; Mason RA; Gabelmann A; Kern P; Kratzer W
Abdom Imaging; 2007 Nov; 32(6):730-6. PubMed ID: 17285403
[TBL] [Abstract][Full Text] [Related]
18. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J
Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817
[TBL] [Abstract][Full Text] [Related]
19.
Ruhlmann M; Ruhlmann J; Görges R; Herrmann K; Antoch G; Keller HW; Ruhlmann V
Thyroid; 2017 Oct; 27(10):1300-1306. PubMed ID: 28793848
[TBL] [Abstract][Full Text] [Related]
20. Physiological 18F-FDG uptake in the normal adult anal canal: evaluation by PET/CT.
Sena Y; Matsumoto S; Silman C; Otsuka K; Kiyota T
Ann Nucl Med; 2020 Aug; 34(8):538-544. PubMed ID: 32430619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
